ERBB2 and breast carcinoma: As shown in Figure 1, 225 patients preliminarily diagnosed with HER2-positive breast cancer were treated with trastuzumab between January 2013 to December 2015 Presence of other malignant tumors was observed in two patients with breast cancers.